NOTCH1 and neoplasm: Therapeutic Strategies: Preclinical studies demonstrate that selective anti-Notch1 monoclonal antibodies (e.g., Omp-18) can significantly attenuate tumor cell proliferative capacity and metastatic dissemination through ligand-binding domain blockade.